Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral Resection
1 other identifier
observational
172
1 country
1
Brief Summary
The purpose of this study was to identify the prognostic factors of affecting pT4bN0M0 colorectal cancer patients, so as to better stratify the prognostic differences among patients with the same stage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 26, 2023
CompletedFirst Submitted
Initial submission to the registry
October 30, 2023
CompletedFirst Posted
Study publicly available on registry
November 3, 2023
CompletedNovember 3, 2023
October 1, 2023
15 days
October 30, 2023
October 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Overall survival
Overall survival is defined as the time from the surgery to death or last follow-up, regardless of disease recurrence, which was measured in months.
The endpoint of the overall survival assessment is the last follow-up or patient death. Follow-up time is up to 72 months.
Cancer specific survival
Cancer specific survival is defined as the time from the diagnosis to death due to cancer progression, which was measured in months.
The endpoint of the cancer specific survival assessment is the patient death due to cancer. Follow-up time is up to 72 months.
Interventions
The prognostic factors were analyzed for pT4bN0M0 colorectal cancer after multivisceral resection
Eligibility Criteria
The patient experienced multivisceral resection for pT4bN0M0 colorectal cancer from January 2010 to December 2021.
You may qualify if:
- The patient was pathologically diagnosed as colorectal adenocarcinoma.
- Patients with pT4bN0M0 colorectal cancer.
- Patients with R0 resection.
You may not qualify if:
- Patients with distant metastasis.
- Patients with R1 or R2 resection.
- Patients with lymph node metastasis
- Recurrent colorectal cancer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, 100021, China
Related Publications (1)
Quan J, Zuo K, Li G, Liu J, Mei S, Hu G, Qiu W, Zhuang M, Meng L, Wang X, Chang H, Tang J. Prognostic stratification of patients with pT4bN0M0 colorectal cancer following multivisceral resection: a multi-institutional case series analysis. Int J Surg. 2024 Sep 1;110(9):5323-5333. doi: 10.1097/JS9.0000000000001646.
PMID: 38768462DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
October 30, 2023
First Posted
November 3, 2023
Study Start
September 1, 2023
Primary Completion
September 16, 2023
Study Completion
September 26, 2023
Last Updated
November 3, 2023
Record last verified: 2023-10